CYP 232 (Ralix 8 mg-2.5 mg-40 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
This pill with imprint "CYP 232" is White, Elliptical / Oval and has been identified as Ralix 8 mg-2.5 mg-40 mg. It is manufactured by Cypress Pharmaceutical Inc.
Ralix is used in the treatment of nasal congestion; rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Ralix 8 mg-2.5 mg-40 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- chlorpheniramine/methscopolamine/phenylephrine
- Imprint:
- CYP 232
- Strength:
- 8 mg-2.5 mg-40 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Cypress Pharmaceutical Inc
- National Drug Code (NDC):
- 60258-0232
More about Ralix (chlorpheniramine / methscopolamine / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Consumer resources
Other brands: Duravent DA, Extendryl Chews, Nohist Plus, DuraTan PE, More... (4)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
